Market Place
Sourcing Support
Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets
18 Sep 2024 //
EXPRESSPHARMA
TWi Pharma`s Generic Dicyclomine Hydrochloride Receives Approval in the U.S.
01 Jun 2023 //
FDA
TWi`s Generic Dicyclomine Hydrochloride Receives Approval in the U.S.
27 Dec 2022 //
FDA
TWi`s Generic Dexlansoprazole Receives Approval in the U.S.
16 Sep 2022 //
FDA
Bora expands its CDMO capabilities, buying TWi Pharma
13 Sep 2022 //
PRESS RELEASE
TWI Pharms`s Generic Guanfacine Hydrochloride Receives Approval in the US
08 Jun 2022 //
FDA
TWI Pharms`s Generic Mycophenolic Acid Receives Approval in the US
03 Nov 2021 //
FDA
Twi Pharms`s Generic Metformin HCl Receives Approval In US
29 Sep 2021 //
FDA
TWI Pharms`s Generic Testosterone Receives Approval in the US
03 Sep 2021 //
FDA
Twi Pharms`s Generic Terbutaline Sulfate Receives Approval in US
24 Jun 2020 //
FDA
TWI Pharma`s Generic Testosterone Receives Approval In US
23 Sep 2019 //
FDA
TWI PHARMS`s generic CHOLINE FENOFIBRATE Receives Approval in US
05 Jul 2019 //
FDA
Twi Pharms`s Generic Metoprolol Succinate Receives Approval in US
19 Dec 2018 //
FDA
Twi Pharms`s Generic Oxcarbazepine Receives Tentative Approval in US
29 Nov 2018 //
FDA
TWi Biotech Announces Last Patient Enrolled in Ph2 Study of AC-201CR
15 Nov 2018 //
PR NEWSWIRE
TWI Pharms`s Generic Diltiazem Hydrochloride Receives Approval in US
06 Sep 2018 //
FDA
Twi Pharm’s Generic Bupropion Hydrochloride Receives Approval In US
08 Nov 2017 //
FDA
TWi Biotechnology Inc. Reports Positive Interim Results from AC-201 CR
24 Dec 2015 //
PR NEWS WIRE
TWi Biotechnology Announces Collaboration with Castle Creek Pharma
16 Dec 2015 //
PR NEWSWIRE
TWi Pharma Receives Favorable Decision from US Court of Appeals
16 Dec 2015 //
PR NEWS WIRE
TWi releases generic version of MEGACE ES (megestrol acetate oral suspension) 625mg/5ml
29 Jul 2015 //
NEWS MEDICAL
TWi Appoints New CEO to Boost US Market
10 Mar 2015 //
BIOSPECTRUM
Up and Down the Ladder: The Latest Comings and Goings at Incyte, Ipsen and…
06 Mar 2015 //
PHARMALOT
TWi Biotechnology`s Lead Drug Candidate AC-201 for Type II Diabetes Receives Chinese Patent
22 Dec 2014 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.